ID   KRBBB_MOUSE             Reviewed;         223 AA.
AC   Q99JB4; Q3TE58; Q497F5; Q7TMP8; Q8BRW0; Q925G5; Q99P32;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Killer cell lectin-like receptor subfamily B member 1B allele B;
DE   AltName: Full=CD161 antigen-like family member B;
DE   AltName: Full=Inhibitory receptor NKR-P1B;
DE   AltName: Full=Lymphocyte antigen 55d;
DE            Short=Ly-55d;
DE   AltName: Full=NKR-P1D;
DE   AltName: Full=Natural killer cell surface protein NKR-P1B allele B6;
DE   AltName: CD_antigen=CD161b;
GN   Name=Klrb1b; Synonyms=Klrb1d, Ly55d, Nkrp1b, Nkrp1d;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND DOMAIN ITIM MOTIF.
RC   STRAIN=C57BL/6J;
RX   PubMed=11685472; DOI=10.1007/s002510100367;
RA   Plougastel B., Matsumoto K., Dubbelde C., Yokoyama W.M.;
RT   "Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of
RT   genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f.";
RL   Immunogenetics 53:592-598(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6NCr;
RA   Carlyle J.R.;
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Ryan J.C., Kumar V., Bennett M., Sivakumar P.V., Niemi E.C., Hayashi S.,
RA   Nakamura M.C.;
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Kung S.K.P., Su R.-C., Shannon J., Miller R.G.;
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Aorta, Head, and Vein;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6NCr; TISSUE=Hematopoietic stem cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=9390275;
RA   Appasamy P.M., Kenniston T.W., Brissette-Storkus C.S., Chambers W.H.;
RT   "NKR-P1dim/TCR alpha beta + T cells and natural killer cells share
RT   expression of NKR-P1A and NKR-P1D.";
RL   Nat. Immunol. 15:259-268(1996).
RN   [8]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=12858173; DOI=10.1038/ni954;
RA   Iizuka K., Naidenko O.V., Plougastel B.F.M., Fremont D.H., Yokoyama W.M.;
RT   "Genetically linked C-type lectin-related ligands for the NKRP1 family of
RT   natural killer cell receptors.";
RL   Nat. Immunol. 4:801-807(2003).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH CLEC2D.
RX   PubMed=14990792; DOI=10.1073/pnas.0308304101;
RA   Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H.,
RA   Raulet D.H.;
RT   "Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer
RT   cell receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3527-3532(2004).
RN   [10]
RP   ANTI-NK1.1 MONOCLONAL ANTIBODY, AND POLYMORPHISM.
RC   STRAIN=BALB/cJ; TISSUE=Spleen;
RX   PubMed=16751398; DOI=10.4049/jimmunol.176.12.7511;
RA   Carlyle J.R., Mesci A., Ljutic B., Belanger S., Tai L.-H., Rousselle E.,
RA   Troke A.D., Proteau M.-F., Makrigiannis A.P.;
RT   "Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of
RT   mouse NK cells.";
RL   J. Immunol. 176:7511-7524(2006).
CC   -!- FUNCTION: Receptor for CLEC2D/OCIL. Ligand-binding contributes to
CC       inhibition of cytotoxic natural killer (NK) cells. May mediate MHC
CC       class I-independent 'missing-self' recognition of allografts, tumor
CC       cells and virus-infected cells. {ECO:0000269|PubMed:12858173,
CC       ECO:0000269|PubMed:14990792}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with tyrosine kinase
CC       LCK. Binds PTPN6/SHP-1 in a phosphorylation-dependent manner.
CC       {ECO:0000269|PubMed:12858173, ECO:0000269|PubMed:14990792}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in NK cells and a subset of T-cells.
CC       {ECO:0000269|PubMed:9390275}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). The
CC       phosphorylated ITIM motif can bind the SH2 domain of several SH2-
CC       containing phosphatases leading to down-regulation of cell activation.
CC       {ECO:0000269|PubMed:11685472}.
CC   -!- POLYMORPHISM: Variants Thr-191 and Ala-191 interfere with binding of
CC       the anti-NK1.1 monoclonal antibody PK136 which identifies NK cells from
CC       C57BL/6 and SJL but not BALB/c mice by binding Klrb1b and Klrb1c in an
CC       allele-dependent manner. Mutagenesis of Thr-191 to Ser-191 restores
CC       NK1.1 reactivity to Klrb1b from BALB/c mice.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF324825; AAL37353.1; -; Genomic_DNA.
DR   EMBL; AF324826; AAL37354.1; -; mRNA.
DR   EMBL; AF338321; AAK08512.1; -; mRNA.
DR   EMBL; AF338322; AAK08513.1; -; mRNA.
DR   EMBL; AF342896; AAK26639.1; -; mRNA.
DR   EMBL; AF354260; AAK39100.1; -; mRNA.
DR   EMBL; AK030702; BAC27088.1; -; mRNA.
DR   EMBL; AK041228; BAC30869.2; -; mRNA.
DR   EMBL; AK169820; BAE41390.1; -; mRNA.
DR   EMBL; BC055379; AAH55379.1; -; mRNA.
DR   EMBL; BC100580; AAI00581.1; -; mRNA.
DR   CCDS; CCDS39655.1; -.
DR   RefSeq; NP_085102.4; NM_030599.4.
DR   PDB; 5TZN; X-ray; 2.60 A; A/W=89-215.
DR   PDB; 6E7D; X-ray; 2.90 A; Q/R/S/T/U/V/W/X=89-215.
DR   PDBsum; 5TZN; -.
DR   PDBsum; 6E7D; -.
DR   AlphaFoldDB; Q99JB4; -.
DR   SMR; Q99JB4; -.
DR   STRING; 10090.ENSMUSP00000032472; -.
DR   MEROPS; I63.002; -.
DR   MaxQB; Q99JB4; -.
DR   PaxDb; Q99JB4; -.
DR   PRIDE; Q99JB4; -.
DR   ProteomicsDB; 265026; -.
DR   DNASU; 80782; -.
DR   Ensembl; ENSMUST00000032472; ENSMUSP00000032472; ENSMUSG00000079298.
DR   GeneID; 80782; -.
DR   KEGG; mmu:80782; -.
DR   UCSC; uc009ees.2; mouse.
DR   CTD; 80782; -.
DR   MGI; MGI:107539; Klrb1b.
DR   VEuPathDB; HostDB:ENSMUSG00000079298; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000154685; -.
DR   HOGENOM; CLU_049894_8_2_1; -.
DR   OMA; TEIRWIC; -.
DR   OrthoDB; 1341815at2759; -.
DR   PhylomeDB; Q99JB4; -.
DR   TreeFam; TF337735; -.
DR   BioGRID-ORCS; 80782; 0 hits in 71 CRISPR screens.
DR   ChiTaRS; Klrb1b; mouse.
DR   Proteomes; UP000000589; Chromosome 6.
DR   Bgee; ENSMUSG00000079298; Expressed in lumbar dorsal root ganglion and 39 other tissues.
DR   ExpressionAtlas; Q99JB4; baseline and differential.
DR   Genevisible; Q99JB4; MM.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:MGI.
DR   GO; GO:0038023; F:signaling receptor activity; IDA:MGI.
DR   GO; GO:0045953; P:negative regulation of natural killer cell mediated cytotoxicity; IDA:MGI.
DR   GO; GO:0042269; P:regulation of natural killer cell mediated cytotoxicity; IBA:GO_Central.
DR   CDD; cd03593; CLECT_NK_receptors_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR033992; NKR-like_CTLD.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Lectin; Membrane; Receptor;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..223
FT                   /note="Killer cell lectin-like receptor subfamily B member
FT                   1B allele B"
FT                   /id="PRO_0000271479"
FT   TOPO_DOM        1..43
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        44..64
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        65..223
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          101..211
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MOTIF           6..11
FT                   /note="ITIM motif"
FT   MOTIF           32..35
FT                   /note="LCK-binding motif"
FT   DISULFID        122..210
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        189..202
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   CONFLICT        68
FT                   /note="K -> E (in Ref. 6; AAH55379)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        78
FT                   /note="V -> I (in Ref. 6; AAH55379/AAI00581)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        131
FT                   /note="L -> P (in Ref. 2; AAK08513)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        139
FT                   /note="R -> G (in Ref. 6; AAI00581)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146
FT                   /note="K -> R (in Ref. 2; AAK08513)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        183
FT                   /note="V -> D (in Ref. 4; AAK39100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        191
FT                   /note="A -> S (in Ref. 4; AAK39100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        191
FT                   /note="A -> T (in Ref. 5; BAE41390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        195
FT                   /note="E -> D (in Ref. 4; AAK39100 and 5; BAE41390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="G -> S (in Ref. 4; AAK39100 and 5; BAE41390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="S -> T (in Ref. 4; AAK39100 and 5; BAE41390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        217
FT                   /note="E -> K (in Ref. 5; BAE41390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="C -> S (in Ref. 4; AAK39100 and 5; BAE41390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        223
FT                   /note="S -> P (in Ref. 6; AAI00581)"
FT                   /evidence="ECO:0000305"
FT   STRAND          99..101
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   HELIX           115..124
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   HELIX           135..143
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   STRAND          150..159
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   TURN            160..163
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   STRAND          188..193
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:5TZN"
FT   STRAND          206..213
FT                   /evidence="ECO:0007829|PDB:5TZN"
SQ   SEQUENCE   223 AA;  25027 MW;  369302CAD529CEC3 CRC64;
     MDSTTLVYAD LNLARIQEPK HDSPPSLSPD TCRCPRWHRL ALKFGCAGLI LLVLVVIGLC
     VLVLSVQKSS VQKICADVQE NRTHTTGCSA KLECPQDWLS HRDKCFHVSQ VSNTWKECRI
     DCDKKGATLL LIQDQEELRF LLDSIKEKYN SFWIGLSYTL TDMNWKWING TAFNSDVLKI
     TGVTENGSCA AISGEKVTSE GCSSDNRWIC QKELNHETPC NDS
//
